Earlier estimates (including on this page) pointed to a Q4 2026 NDA filing based on TRIUMPH-1 and TRIUMPH-4 data alone
2023: Tirezepatide (Zepbound) receives FDA approval for weight loss
However, the American Academy of Pediatrics recommends screening jaundiced newborns who undergo phototherapy, especially if they have a family history of the deficiency or are of African, Asian, or Mediterranean descent ( Children with G6PD deficiency can lead a typical lifestyle, as long as they avoid any known triggers
We believe plan sponsors should start preparing now for increased demand and develop a program approach that balances providing access with maintaining benefit affordability.
I'll actually look for ways to get more steps in now, or even if I have to walk extra, just because I want it
What works for one person may not work the same way for another, and thats perfectly okay